The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment outcomes of patients with mIDH1 cholangiocarcinoma in the United States.
 
Rachna Shroff
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Boston Scientific; Genentech; Ipsen; Merus; Regeneron
Research Funding - Actuate Therapeutics; Arcus Biosciences; Compass Therapeutics; Exelixis; Fujifilm; Lisata; Loxo/Lilly; Merck; NGM Biopharmaceuticals; Novocure
 
Lorenza Rimassa
Honoraria - Abbvie; Amgen; AstraZeneca; AstraZeneca; Bayer; Biologix FZC; Bristol-Myers Squibb Italy; Eisai; Eisai; Gilead Sciences; Guerbet; Incyte; Ipsen; Lilly; Merck Serono; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Abbvie; Amgen; ArQule; AstraZeneca; Basilea; Baxter; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Eisai; Eisai; Elevar Therapeutics; Exelixis; Genenta Science; Guerbet; Hengrui Therapeutics; Incyte; Ipsen; IQvia; Italfarmaco; Jazz Pharmaceuticals; Lilly; Merck Sharp & Dohme; Nerviano Medical Sciences; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Oncology; Zymeworks; Zymeworks
Research Funding - Abbvie (Inst); Agios (Inst); ARMO BioSciences (Inst); ArQule (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Eisai (Inst); Exelixis (Inst); Exelixis/Ipsen (Inst); FibroGen (Inst); Incyte (Inst); Ipsen (Inst); Jazz Pharmaceuticals; Lilly (Inst); Merck Sharp & Dohme (Inst); Nerviano Medical Sciences (Inst); Roche; SERVIER (Inst); Taiho Oncology (Inst); TransThera Sciences (Nanjing), Inc. (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - ArQule; AstraZeneca; Ipsen; SERVIER
 
Juan Valle
Consulting or Advisory Role - AstraZeneca; Cogent Biosciences (Inst); Incyte; Jazz Pharmaceuticals; Jazz Pharmaceuticals (Inst); Oncosil (Inst); Owkin (Inst); Redx Pharma (Inst); SERVIER; Taiho Oncology
 
Valerie Gunchick
Consulting or Advisory Role - Cornerstone Pharmaceuticals; SERVIER
 
Hakam Gharbi
Employment - SERVIER
 
Renata Robert
Employment - SERVIER
 
Vaibhav Sahai
Consulting or Advisory Role - AstraZeneca; Autem Medical; Civala; Civala; Delcath Systems; Elevar Therapeutics; Histosonics; Incyte; Ipsen; Jazz Pharmaceuticals; Lynx Group; Revolution Medicines; SERVIER; Tallac Therapeutics; TransThera Biosciences
Research Funding - Actuate Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Elicio Therapeutics (Inst); Esanik (Inst); Exelixis (Inst); FibroGen (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); MedImmune (Inst); Pancreatic Cancer Action Network (Inst); Rafael Pharmaceuticals (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst); Repare Therapeutics (Inst); SERVIER (Inst); Syros Pharmaceuticals (Inst); TransThera Biosciences (Inst)
Other Relationship - Rafael Pharmaceuticals (Inst)